Le site français est toujours en construction. Rendez-vous en janvier ! Pour nous contacter, cliquer ici.
Pour accéder à la plateforme Pharmaciens, cliquer ici.

FR
Menu
Insights

Defining a patient strategy for emerging markets

What is the best approach for defining patient services strategy for premium treatments in emerging, out-of-pocket markets?

Specialized “premium” therapy sales in growth markets is a strategic focus in the industry, and patient services offerings play an increasing role in achieving this goal. The development of patient programs in developing countries requires calibration to nuances of the local context, particularly for out-of-pocket markets.


What is the best approach for defining patient services strategy for premium treatments in emerging, out-of-pocket markets?

This white paper has been written by our consultants Kevin Maples and Francesca Schneller

 

Please fill in the form to download Whitepaper :

couverture Defining a patient strategy for emerging markets

We are processing this data per your request only. We are hosting the data internally. We will not share it.

Here’s a link to our privacy policy. You can find out how to send a request to access your data, request to delete your data, correct any inaccuracies or restrict our processing of your data.

You have the right to lodge a complaint about the way we handle your data with French Data Protection authority CNIL or you can contact our DPO at contact form for more information or with concerns.

Share

See also

Scientific communications

SPUR™ Phase 2 US study: publication’s results

Articles

(R)evolution in healthtech: pharma companies must take the reins

News

Already 10 Years Spent Together

Accès plateformes